HemoGenyx LLC, a privately held biopharmaceutical company, is developing new methods of hematopoietic system regeneration. Our goal is to eliminate the need for allogeneic bone marrow transplantations from medical practice and drastically improve autologous ones. We propose a new approach that is ba…
HemoGenyx LLC, a privately held biopharmaceutical company, is developing new methods of hematopoietic system regeneration. Our goal is to eliminate the need for allogeneic bone marrow transplantations from medical practice and drastically improve autologous ones. We propose a new approach that is based on the use of a novel type of hemogenic cells that are 100% patient-matched and have not undergone the malignant transformations that are responsible for most leukemias and lymphomas.
Team (1)
Sectors HemoGenyx LLC serves:
Life Sciences
Join Axial's Private M&A Platform
HemoGenyx LLC connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
